Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Metabolomics | 37 | 2024 | 1656 | 5.010 |
Why?
|
Renal Insufficiency, Chronic | 46 | 2024 | 2252 | 4.820 |
Why?
|
Metabolome | 26 | 2024 | 988 | 3.720 |
Why?
|
Kidney | 24 | 2024 | 7044 | 2.070 |
Why?
|
Acute Kidney Injury | 13 | 2024 | 1923 | 2.000 |
Why?
|
Nephrology | 3 | 2022 | 263 | 1.630 |
Why?
|
Proteomics | 13 | 2024 | 3836 | 1.610 |
Why?
|
Phosphates | 4 | 2024 | 769 | 1.530 |
Why?
|
NAD | 6 | 2023 | 614 | 1.510 |
Why?
|
Uremia | 5 | 2024 | 202 | 1.440 |
Why?
|
Diabetic Nephropathies | 5 | 2022 | 972 | 1.340 |
Why?
|
Fibroblast Growth Factors | 7 | 2024 | 865 | 1.330 |
Why?
|
Kidney Failure, Chronic | 13 | 2024 | 2474 | 1.270 |
Why?
|
Kidney Diseases | 7 | 2024 | 2090 | 1.150 |
Why?
|
Renal Dialysis | 7 | 2024 | 1795 | 0.960 |
Why?
|
Proteome | 7 | 2023 | 1857 | 0.960 |
Why?
|
Glomerular Filtration Rate | 21 | 2024 | 2174 | 0.950 |
Why?
|
Glycolysis | 4 | 2024 | 835 | 0.830 |
Why?
|
Serum Albumin | 4 | 2024 | 673 | 0.790 |
Why?
|
Swimming | 1 | 2022 | 208 | 0.750 |
Why?
|
Genome-Wide Association Study | 10 | 2023 | 12661 | 0.740 |
Why?
|
Pyridinium Compounds | 1 | 2020 | 81 | 0.710 |
Why?
|
Glycerophosphates | 1 | 2020 | 47 | 0.700 |
Why?
|
Glycerol | 1 | 2021 | 275 | 0.690 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2023 | 540 | 0.680 |
Why?
|
Niacinamide | 3 | 2020 | 413 | 0.670 |
Why?
|
Stilbenes | 1 | 2020 | 155 | 0.670 |
Why?
|
Hypertension | 12 | 2024 | 8532 | 0.660 |
Why?
|
Creatinine | 4 | 2023 | 1895 | 0.650 |
Why?
|
Diabetes Mellitus | 8 | 2023 | 5838 | 0.620 |
Why?
|
Parathyroid Hormone | 4 | 2024 | 1803 | 0.610 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 4 | 2024 | 225 | 0.580 |
Why?
|
Proteoglycans | 1 | 2020 | 803 | 0.570 |
Why?
|
Carnitine | 2 | 2018 | 252 | 0.540 |
Why?
|
Atherosclerosis | 5 | 2023 | 3400 | 0.530 |
Why?
|
Homeostasis | 3 | 2024 | 3321 | 0.530 |
Why?
|
Robotics | 1 | 2022 | 817 | 0.500 |
Why?
|
Fumarate Hydratase | 1 | 2015 | 52 | 0.490 |
Why?
|
RNA, Small Interfering | 1 | 2024 | 3419 | 0.480 |
Why?
|
Renal Circulation | 1 | 2015 | 291 | 0.470 |
Why?
|
Renal Artery Obstruction | 1 | 2015 | 218 | 0.450 |
Why?
|
Humans | 117 | 2024 | 760740 | 0.420 |
Why?
|
Mass Spectrometry | 9 | 2017 | 2189 | 0.420 |
Why?
|
Plasma | 1 | 2016 | 586 | 0.420 |
Why?
|
Metabolic Networks and Pathways | 4 | 2022 | 789 | 0.410 |
Why?
|
Chromatography, Liquid | 7 | 2016 | 982 | 0.400 |
Why?
|
Outpatients | 1 | 2020 | 1596 | 0.400 |
Why?
|
Pseudouridine | 2 | 2022 | 19 | 0.400 |
Why?
|
Triglycerides | 4 | 2013 | 2459 | 0.380 |
Why?
|
Thyrotoxicosis | 1 | 2012 | 85 | 0.380 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2014 | 693 | 0.370 |
Why?
|
Bronchiolitis | 3 | 2023 | 485 | 0.370 |
Why?
|
Hypokalemia | 1 | 2012 | 153 | 0.360 |
Why?
|
Paralysis | 1 | 2012 | 250 | 0.350 |
Why?
|
Cardiovascular Diseases | 9 | 2024 | 15498 | 0.350 |
Why?
|
Kidney Function Tests | 3 | 2020 | 677 | 0.350 |
Why?
|
Graves Disease | 1 | 2012 | 238 | 0.350 |
Why?
|
Methylamines | 4 | 2022 | 136 | 0.350 |
Why?
|
Male | 68 | 2024 | 360402 | 0.340 |
Why?
|
Alanine | 3 | 2021 | 609 | 0.330 |
Why?
|
Adenosine Monophosphate | 2 | 2020 | 231 | 0.310 |
Why?
|
Middle Aged | 47 | 2024 | 220603 | 0.300 |
Why?
|
Kidney Transplantation | 1 | 2023 | 4218 | 0.290 |
Why?
|
Aged | 43 | 2024 | 169092 | 0.280 |
Why?
|
Immunologic Factors | 2 | 2020 | 1589 | 0.280 |
Why?
|
Female | 62 | 2024 | 392203 | 0.280 |
Why?
|
Heart Diseases | 1 | 2020 | 2778 | 0.270 |
Why?
|
Tryptophan | 4 | 2021 | 482 | 0.270 |
Why?
|
Quality of Life | 5 | 2024 | 13359 | 0.260 |
Why?
|
Pruritus | 4 | 2024 | 378 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3088 | 0.250 |
Why?
|
Calcitriol | 2 | 2023 | 296 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3209 | 0.250 |
Why?
|
Amino Acids | 4 | 2020 | 1718 | 0.250 |
Why?
|
Podocytes | 2 | 2020 | 405 | 0.240 |
Why?
|
Eicosanoids | 2 | 2023 | 282 | 0.240 |
Why?
|
Cohort Studies | 17 | 2024 | 41464 | 0.240 |
Why?
|
Animals | 25 | 2024 | 168202 | 0.230 |
Why?
|
Citrulline | 1 | 2024 | 107 | 0.230 |
Why?
|
Proteinuria | 2 | 2024 | 605 | 0.230 |
Why?
|
Disease Progression | 10 | 2024 | 13495 | 0.230 |
Why?
|
Myristates | 1 | 2023 | 12 | 0.230 |
Why?
|
Lipids | 2 | 2014 | 3332 | 0.220 |
Why?
|
Glucokinase | 1 | 2023 | 102 | 0.220 |
Why?
|
Furin | 1 | 2023 | 46 | 0.220 |
Why?
|
Aortic Valve Stenosis | 4 | 2021 | 2003 | 0.220 |
Why?
|
Obesity | 6 | 2021 | 12934 | 0.210 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2024 | 147 | 0.210 |
Why?
|
Insulin Resistance | 5 | 2016 | 3954 | 0.210 |
Why?
|
Glomerulonephritis, Membranous | 2 | 2020 | 87 | 0.210 |
Why?
|
Osteopontin | 1 | 2024 | 301 | 0.200 |
Why?
|
Bees | 1 | 2022 | 46 | 0.200 |
Why?
|
Aptamers, Nucleotide | 1 | 2024 | 164 | 0.200 |
Why?
|
Acetyltransferases | 2 | 2020 | 231 | 0.200 |
Why?
|
Dyslipidemias | 4 | 2016 | 868 | 0.200 |
Why?
|
Genomics | 1 | 2018 | 5822 | 0.200 |
Why?
|
Kidney Tubules | 2 | 2024 | 449 | 0.200 |
Why?
|
Albuminuria | 3 | 2023 | 655 | 0.190 |
Why?
|
Prospective Studies | 19 | 2024 | 54364 | 0.190 |
Why?
|
Lung | 1 | 2020 | 9999 | 0.190 |
Why?
|
Cross-Sectional Studies | 12 | 2024 | 26065 | 0.190 |
Why?
|
Hydrodynamics | 1 | 2022 | 168 | 0.190 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2022 | 15908 | 0.190 |
Why?
|
Liver | 4 | 2024 | 7512 | 0.190 |
Why?
|
Hypercalcemia | 1 | 2024 | 423 | 0.190 |
Why?
|
Uridine | 1 | 2021 | 140 | 0.180 |
Why?
|
Case-Control Studies | 10 | 2023 | 22153 | 0.180 |
Why?
|
Hand Strength | 1 | 2024 | 456 | 0.180 |
Why?
|
Micropore Filters | 1 | 2020 | 22 | 0.180 |
Why?
|
Aptamers, Peptide | 1 | 2020 | 28 | 0.180 |
Why?
|
Risk Factors | 20 | 2023 | 74128 | 0.180 |
Why?
|
Orbital Pseudotumor | 1 | 2020 | 42 | 0.180 |
Why?
|
Common Cold | 1 | 2020 | 63 | 0.180 |
Why?
|
Lipoxygenase | 1 | 2020 | 72 | 0.170 |
Why?
|
Genome, Human | 1 | 2013 | 4421 | 0.170 |
Why?
|
Ketoglutaric Acids | 1 | 2020 | 76 | 0.170 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2020 | 77 | 0.170 |
Why?
|
Locomotion | 1 | 2022 | 388 | 0.170 |
Why?
|
Biomarkers, Pharmacological | 1 | 2020 | 161 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2021 | 12143 | 0.170 |
Why?
|
Calcium Channels | 1 | 2023 | 620 | 0.170 |
Why?
|
Sodium, Dietary | 1 | 2023 | 425 | 0.170 |
Why?
|
Nephritis, Interstitial | 1 | 2020 | 155 | 0.160 |
Why?
|
Rhinovirus | 1 | 2020 | 203 | 0.160 |
Why?
|
Hydroxyeicosatetraenoic Acids | 1 | 2020 | 224 | 0.160 |
Why?
|
Nitrogen | 1 | 2020 | 345 | 0.160 |
Why?
|
Coenzyme A | 1 | 2018 | 39 | 0.160 |
Why?
|
Mice, Knockout | 4 | 2024 | 14388 | 0.160 |
Why?
|
Lacrimal Apparatus | 1 | 2020 | 223 | 0.160 |
Why?
|
Asthma | 3 | 2023 | 6234 | 0.150 |
Why?
|
Dietary Proteins | 1 | 2023 | 951 | 0.150 |
Why?
|
Perfusion | 1 | 2023 | 1373 | 0.150 |
Why?
|
Oxidative Phosphorylation | 1 | 2020 | 495 | 0.150 |
Why?
|
Kidney Glomerulus | 1 | 2020 | 568 | 0.150 |
Why?
|
Phenotype | 7 | 2021 | 16572 | 0.150 |
Why?
|
Biosynthetic Pathways | 1 | 2018 | 135 | 0.150 |
Why?
|
Amides | 1 | 2020 | 449 | 0.140 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2020 | 412 | 0.140 |
Why?
|
Mammals | 1 | 2023 | 1131 | 0.140 |
Why?
|
Amino Acid Transport Systems, Basic | 1 | 2017 | 33 | 0.140 |
Why?
|
Deoxyglucose | 1 | 2018 | 333 | 0.140 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2017 | 68 | 0.140 |
Why?
|
Amino Acids, Branched-Chain | 3 | 2018 | 269 | 0.140 |
Why?
|
Analytic Sample Preparation Methods | 1 | 2016 | 7 | 0.140 |
Why?
|
Hypotension | 1 | 2023 | 879 | 0.140 |
Why?
|
Linkage Disequilibrium | 1 | 2022 | 1994 | 0.140 |
Why?
|
Blood Pressure | 3 | 2024 | 8473 | 0.140 |
Why?
|
Adenosine | 1 | 2021 | 805 | 0.130 |
Why?
|
Mitochondrial Diseases | 1 | 2020 | 343 | 0.130 |
Why?
|
Oxidoreductases | 1 | 2018 | 412 | 0.130 |
Why?
|
Amino Acids, Aromatic | 2 | 2013 | 36 | 0.130 |
Why?
|
Xanthines | 1 | 2016 | 120 | 0.130 |
Why?
|
Ribonucleosides | 1 | 2016 | 79 | 0.130 |
Why?
|
S-Adenosylhomocysteine | 1 | 2016 | 41 | 0.130 |
Why?
|
Penile Implantation | 1 | 2015 | 11 | 0.130 |
Why?
|
Aged, 80 and over | 11 | 2021 | 58919 | 0.130 |
Why?
|
Penile Prosthesis | 1 | 2015 | 32 | 0.130 |
Why?
|
Isocitrates | 1 | 2015 | 23 | 0.130 |
Why?
|
Neutropenia | 1 | 2020 | 885 | 0.130 |
Why?
|
Taurocholic Acid | 1 | 2015 | 43 | 0.130 |
Why?
|
Cell Line | 6 | 2023 | 15577 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2020 | 10754 | 0.120 |
Why?
|
Mice | 15 | 2024 | 81368 | 0.120 |
Why?
|
Renal Veins | 1 | 2015 | 102 | 0.120 |
Why?
|
Adult | 20 | 2024 | 220995 | 0.120 |
Why?
|
Diet, Mediterranean | 1 | 2021 | 738 | 0.120 |
Why?
|
Death | 1 | 2019 | 674 | 0.120 |
Why?
|
Drug Monitoring | 1 | 2020 | 960 | 0.120 |
Why?
|
HEK293 Cells | 3 | 2019 | 4269 | 0.120 |
Why?
|
Animal Structures | 1 | 2014 | 24 | 0.120 |
Why?
|
Transplantation, Homologous | 1 | 2023 | 4802 | 0.120 |
Why?
|
Drug Combinations | 1 | 2020 | 2048 | 0.110 |
Why?
|
Pyrazines | 1 | 2020 | 1202 | 0.110 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 934 | 0.110 |
Why?
|
Systems Biology | 1 | 2018 | 481 | 0.110 |
Why?
|
Logistic Models | 7 | 2022 | 13248 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2016 | 3769 | 0.110 |
Why?
|
Bone Resorption | 1 | 2018 | 723 | 0.110 |
Why?
|
Receptors, Cell Surface | 1 | 2023 | 2802 | 0.110 |
Why?
|
Minerals | 1 | 2015 | 283 | 0.110 |
Why?
|
2-Aminoadipic Acid | 1 | 2013 | 32 | 0.110 |
Why?
|
Cholesterol Esters | 1 | 2013 | 73 | 0.110 |
Why?
|
Radiography, Thoracic | 1 | 2020 | 1302 | 0.110 |
Why?
|
Tissue Donors | 1 | 2023 | 2329 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1504 | 0.110 |
Why?
|
Heparin | 1 | 2020 | 1632 | 0.110 |
Why?
|
Fever | 1 | 2020 | 1618 | 0.110 |
Why?
|
Risk Assessment | 7 | 2024 | 23974 | 0.100 |
Why?
|
Immunosuppressive Agents | 3 | 2024 | 4172 | 0.100 |
Why?
|
Urology | 1 | 2017 | 400 | 0.100 |
Why?
|
Transaminases | 1 | 2013 | 199 | 0.100 |
Why?
|
Paralysis, Hyperkalemic Periodic | 1 | 2012 | 5 | 0.100 |
Why?
|
Odds Ratio | 5 | 2017 | 9644 | 0.100 |
Why?
|
Muscle Cramp | 1 | 2012 | 34 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2019 | 15250 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2018 | 1250 | 0.100 |
Why?
|
Paresthesia | 2 | 2024 | 162 | 0.100 |
Why?
|
Chromatography, Gas | 1 | 2011 | 151 | 0.100 |
Why?
|
Erectile Dysfunction | 1 | 2015 | 444 | 0.100 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18220 | 0.100 |
Why?
|
Glucose Tolerance Test | 2 | 2013 | 1178 | 0.090 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 3410 | 0.090 |
Why?
|
Adipocytes, White | 1 | 2012 | 90 | 0.090 |
Why?
|
Nucleotides | 2 | 2012 | 453 | 0.090 |
Why?
|
Adipocytes, Brown | 1 | 2012 | 150 | 0.090 |
Why?
|
Recurrence | 4 | 2024 | 8426 | 0.090 |
Why?
|
Antiviral Agents | 2 | 2020 | 3037 | 0.090 |
Why?
|
Insulin | 4 | 2013 | 6593 | 0.090 |
Why?
|
Drug Administration Schedule | 3 | 2020 | 4845 | 0.090 |
Why?
|
Bone and Bones | 1 | 2021 | 2565 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1810 | 0.090 |
Why?
|
Biogenic Amines | 1 | 2010 | 53 | 0.090 |
Why?
|
Massachusetts | 4 | 2020 | 8835 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2899 | 0.090 |
Why?
|
Ventricular Remodeling | 1 | 2018 | 1265 | 0.090 |
Why?
|
Adipocytes | 1 | 2017 | 1187 | 0.090 |
Why?
|
Phosphatidylcholines | 1 | 2011 | 405 | 0.090 |
Why?
|
Mice, Inbred C57BL | 6 | 2019 | 22117 | 0.090 |
Why?
|
Dicarboxylic Acids | 1 | 2010 | 77 | 0.080 |
Why?
|
Sphingomyelins | 1 | 2010 | 105 | 0.080 |
Why?
|
Data Interpretation, Statistical | 1 | 2020 | 2689 | 0.080 |
Why?
|
Pilot Projects | 2 | 2020 | 8619 | 0.080 |
Why?
|
Cause of Death | 1 | 2020 | 3683 | 0.080 |
Why?
|
Molecular Structure | 2 | 2011 | 1878 | 0.080 |
Why?
|
Kynurenic Acid | 1 | 2009 | 44 | 0.080 |
Why?
|
Myocardium | 2 | 2020 | 4725 | 0.080 |
Why?
|
Gene Frequency | 1 | 2016 | 3601 | 0.080 |
Why?
|
Body Mass Index | 3 | 2016 | 12942 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2020 | 12333 | 0.080 |
Why?
|
Blood Proteins | 2 | 2024 | 1172 | 0.080 |
Why?
|
Muscle Weakness | 1 | 2012 | 412 | 0.080 |
Why?
|
B-Lymphocytes | 2 | 2014 | 4745 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2238 | 0.080 |
Why?
|
Transgenes | 1 | 2012 | 1008 | 0.080 |
Why?
|
Histidine | 2 | 2020 | 308 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2021 | 12043 | 0.080 |
Why?
|
Glomerulosclerosis, Focal Segmental | 2 | 2022 | 335 | 0.070 |
Why?
|
Oxidation-Reduction | 3 | 2019 | 2231 | 0.070 |
Why?
|
Anticoagulants | 2 | 2020 | 4785 | 0.070 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 2019 | 354 | 0.070 |
Why?
|
Cells, Cultured | 3 | 2019 | 18937 | 0.070 |
Why?
|
Critical Illness | 1 | 2020 | 2709 | 0.070 |
Why?
|
Blood | 1 | 2010 | 596 | 0.070 |
Why?
|
Longevity | 1 | 2015 | 1064 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3533 | 0.070 |
Why?
|
Prognosis | 4 | 2024 | 29601 | 0.070 |
Why?
|
Blood Glucose | 4 | 2016 | 6390 | 0.070 |
Why?
|
Prediabetic State | 1 | 2013 | 545 | 0.070 |
Why?
|
Time Factors | 5 | 2021 | 39908 | 0.070 |
Why?
|
Epidemiologic Methods | 1 | 2011 | 1335 | 0.070 |
Why?
|
Sepsis | 1 | 2020 | 2585 | 0.070 |
Why?
|
Incidence | 4 | 2023 | 21339 | 0.070 |
Why?
|
Mitochondria | 2 | 2016 | 3619 | 0.070 |
Why?
|
Phenols | 1 | 2010 | 516 | 0.070 |
Why?
|
Cholesterol | 1 | 2015 | 2902 | 0.070 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6305 | 0.070 |
Why?
|
Longitudinal Studies | 5 | 2024 | 14599 | 0.060 |
Why?
|
Proportional Hazards Models | 4 | 2024 | 12448 | 0.060 |
Why?
|
Fatigue | 2 | 2024 | 1550 | 0.060 |
Why?
|
Phosphorus Metabolism Disorders | 1 | 2005 | 9 | 0.060 |
Why?
|
Transcription Factors | 4 | 2023 | 12116 | 0.060 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2016 | 1553 | 0.060 |
Why?
|
Lipid Metabolism | 1 | 2014 | 1896 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2015 | 2018 | 0.060 |
Why?
|
Prevalence | 2 | 2020 | 15702 | 0.060 |
Why?
|
Pluripotent Stem Cells | 1 | 2012 | 796 | 0.060 |
Why?
|
Treatment Outcome | 7 | 2024 | 64572 | 0.060 |
Why?
|
Tenascin | 1 | 2024 | 61 | 0.060 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2005 | 125 | 0.060 |
Why?
|
Quantitative Trait Loci | 2 | 2023 | 2112 | 0.060 |
Why?
|
Remission Induction | 2 | 2024 | 2391 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6174 | 0.060 |
Why?
|
Diet, Protein-Restricted | 1 | 2023 | 72 | 0.050 |
Why?
|
Hypophosphatemia | 1 | 2024 | 92 | 0.050 |
Why?
|
Pandemics | 2 | 2020 | 8652 | 0.050 |
Why?
|
Exercise Test | 1 | 2011 | 2127 | 0.050 |
Why?
|
Infant | 5 | 2023 | 36157 | 0.050 |
Why?
|
Mice, Nude | 2 | 2020 | 3606 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 6403 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 1 | 2009 | 1834 | 0.050 |
Why?
|
Deoxycholic Acid | 1 | 2022 | 53 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12966 | 0.050 |
Why?
|
Cystatin C | 1 | 2023 | 270 | 0.050 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2024 | 289 | 0.050 |
Why?
|
Sugar Acids | 1 | 2021 | 24 | 0.050 |
Why?
|
Muscle, Skeletal | 2 | 2021 | 4947 | 0.050 |
Why?
|
Methylhistidines | 1 | 2020 | 35 | 0.050 |
Why?
|
Citrates | 1 | 2021 | 133 | 0.050 |
Why?
|
Diet, Sodium-Restricted | 1 | 2023 | 291 | 0.050 |
Why?
|
Ornithine | 1 | 2020 | 79 | 0.050 |
Why?
|
Filgrastim | 1 | 2020 | 132 | 0.050 |
Why?
|
Histamine | 1 | 2022 | 499 | 0.050 |
Why?
|
Diet | 3 | 2023 | 8049 | 0.050 |
Why?
|
Plants | 1 | 2022 | 327 | 0.050 |
Why?
|
Nausea | 1 | 2024 | 679 | 0.050 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2023 | 852 | 0.050 |
Why?
|
Nephrosis, Lipoid | 1 | 2020 | 45 | 0.040 |
Why?
|
Diet, Vegetarian | 1 | 2022 | 180 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 3085 | 0.040 |
Why?
|
Sulfides | 1 | 2021 | 169 | 0.040 |
Why?
|
Hematologic Agents | 1 | 2020 | 40 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39062 | 0.040 |
Why?
|
Child | 6 | 2024 | 80089 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 3 | 2022 | 17878 | 0.040 |
Why?
|
Oxides | 1 | 2022 | 401 | 0.040 |
Why?
|
Weight Loss | 1 | 2012 | 2682 | 0.040 |
Why?
|
Telemedicine | 1 | 2017 | 3051 | 0.040 |
Why?
|
Dairy Products | 1 | 2023 | 490 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12719 | 0.040 |
Why?
|
Factor Xa | 1 | 2020 | 166 | 0.040 |
Why?
|
Sugar Alcohols | 1 | 2019 | 18 | 0.040 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2017 | 499 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15609 | 0.040 |
Why?
|
Malates | 1 | 2019 | 34 | 0.040 |
Why?
|
Azathioprine | 1 | 2020 | 354 | 0.040 |
Why?
|
Ketone Bodies | 1 | 2019 | 76 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 281 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2010 | 2878 | 0.040 |
Why?
|
Neoplasms | 2 | 2020 | 22131 | 0.040 |
Why?
|
Aldehyde Reductase | 1 | 2018 | 70 | 0.040 |
Why?
|
Transcription Factors, TFII | 1 | 1998 | 62 | 0.040 |
Why?
|
Pentosyltransferases | 1 | 2018 | 62 | 0.040 |
Why?
|
Quinolinic Acid | 1 | 2018 | 67 | 0.040 |
Why?
|
NADP | 1 | 2019 | 227 | 0.040 |
Why?
|
Gait | 1 | 2024 | 811 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2020 | 348 | 0.040 |
Why?
|
Electrocardiography | 1 | 2012 | 6346 | 0.040 |
Why?
|
Ischemia | 2 | 2018 | 1885 | 0.040 |
Why?
|
Intelligence | 1 | 2023 | 923 | 0.040 |
Why?
|
Acetylcarnitine | 1 | 2018 | 9 | 0.040 |
Why?
|
Indican | 1 | 2018 | 16 | 0.040 |
Why?
|
Pentose Phosphate Pathway | 1 | 2018 | 126 | 0.040 |
Why?
|
Cresols | 1 | 2018 | 26 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2021 | 455 | 0.040 |
Why?
|
Nasopharynx | 1 | 2021 | 400 | 0.040 |
Why?
|
Arginine | 1 | 2022 | 933 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2024 | 998 | 0.040 |
Why?
|
Sulfuric Acid Esters | 1 | 2018 | 32 | 0.040 |
Why?
|
Equipment Failure Analysis | 1 | 2020 | 843 | 0.040 |
Why?
|
Acetylation | 1 | 2020 | 1055 | 0.040 |
Why?
|
TATA-Binding Protein Associated Factors | 1 | 1998 | 103 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 2020 | 1376 | 0.040 |
Why?
|
Sodium | 1 | 2023 | 1588 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2019 | 426 | 0.040 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 587 | 0.040 |
Why?
|
omega-N-Methylarginine | 1 | 2017 | 108 | 0.040 |
Why?
|
Kynurenine | 1 | 2018 | 141 | 0.040 |
Why?
|
Calcification, Physiologic | 1 | 2018 | 170 | 0.040 |
Why?
|
Boston | 1 | 2010 | 9313 | 0.040 |
Why?
|
Memory, Short-Term | 1 | 2023 | 982 | 0.030 |
Why?
|
Pyruvate Kinase | 1 | 2018 | 189 | 0.030 |
Why?
|
Cytoskeleton | 1 | 2022 | 1170 | 0.030 |
Why?
|
Eating | 1 | 2023 | 1535 | 0.030 |
Why?
|
Sirtuins | 1 | 2019 | 319 | 0.030 |
Why?
|
Walking | 1 | 2024 | 1197 | 0.030 |
Why?
|
Kidney Tubules, Proximal | 1 | 2018 | 382 | 0.030 |
Why?
|
Ubiquitin | 1 | 2021 | 839 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2009 | 3550 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2017 | 3776 | 0.030 |
Why?
|
Child, Preschool | 3 | 2024 | 42193 | 0.030 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2016 | 72 | 0.030 |
Why?
|
Hydroxamic Acids | 1 | 2019 | 481 | 0.030 |
Why?
|
Choline | 1 | 2018 | 515 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2014 | 2703 | 0.030 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 1 | 2016 | 83 | 0.030 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2018 | 705 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2020 | 2218 | 0.030 |
Why?
|
Executive Function | 1 | 2023 | 1391 | 0.030 |
Why?
|
Urinalysis | 1 | 2017 | 368 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1436 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2020 | 1154 | 0.030 |
Why?
|
RNA Polymerase II | 1 | 1998 | 537 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1998 | 907 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6473 | 0.030 |
Why?
|
Adolescent | 4 | 2024 | 88247 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2012 | 11512 | 0.030 |
Why?
|
Age Factors | 2 | 2021 | 18381 | 0.030 |
Why?
|
Methotrexate | 1 | 2020 | 1716 | 0.030 |
Why?
|
Mesenchymal Stem Cells | 2 | 2017 | 1642 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2021 | 80583 | 0.030 |
Why?
|
Brazil | 1 | 2018 | 1229 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1788 | 0.030 |
Why?
|
Glycine | 1 | 2017 | 661 | 0.030 |
Why?
|
Glipizide | 1 | 2013 | 48 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2327 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10203 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2018 | 982 | 0.030 |
Why?
|
Exercise | 1 | 2010 | 5886 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4569 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2021 | 1819 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 1988 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2023 | 2896 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2447 | 0.030 |
Why?
|
Dinoprostone | 1 | 2016 | 597 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 2019 | 1023 | 0.030 |
Why?
|
Tissue Culture Techniques | 1 | 2013 | 289 | 0.030 |
Why?
|
Lysine | 1 | 2017 | 993 | 0.030 |
Why?
|
American Heart Association | 1 | 2017 | 1039 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15829 | 0.020 |
Why?
|
Biopsy | 1 | 2024 | 6763 | 0.020 |
Why?
|
RNA | 1 | 2022 | 2713 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3599 | 0.020 |
Why?
|
Glucose | 1 | 2023 | 4345 | 0.020 |
Why?
|
North America | 1 | 2015 | 1273 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2012 | 102 | 0.020 |
Why?
|
Preoperative Care | 1 | 2020 | 2242 | 0.020 |
Why?
|
Protein Kinases | 1 | 1998 | 1606 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2013 | 452 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2018 | 1315 | 0.020 |
Why?
|
Risk | 2 | 2013 | 9603 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20077 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2022 | 3095 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3115 | 0.020 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2010 | 67 | 0.020 |
Why?
|
3T3 Cells | 1 | 2012 | 1085 | 0.020 |
Why?
|
Area Under Curve | 1 | 2014 | 1635 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2014 | 2261 | 0.020 |
Why?
|
Vitamin D | 1 | 2023 | 3301 | 0.020 |
Why?
|
Fasting | 1 | 2016 | 1603 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1998 | 1836 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2014 | 2214 | 0.020 |
Why?
|
Glutamine | 1 | 2012 | 576 | 0.020 |
Why?
|
Adipose Tissue, White | 1 | 2012 | 359 | 0.020 |
Why?
|
PPAR gamma | 1 | 2012 | 484 | 0.020 |
Why?
|
Organ Specificity | 1 | 2013 | 1964 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2016 | 1403 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2012 | 9586 | 0.020 |
Why?
|
Waist Circumference | 1 | 2012 | 933 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2020 | 2152 | 0.020 |
Why?
|
Rheology | 1 | 2009 | 347 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4117 | 0.020 |
Why?
|
Patient Admission | 1 | 2015 | 1365 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 1998 | 2674 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36401 | 0.020 |
Why?
|
United States | 3 | 2023 | 72292 | 0.020 |
Why?
|
Signal Transduction | 2 | 2024 | 23415 | 0.020 |
Why?
|
Prostatectomy | 1 | 2015 | 1825 | 0.020 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2009 | 446 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5062 | 0.020 |
Why?
|
Insulin-Secreting Cells | 1 | 2013 | 898 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 6988 | 0.020 |
Why?
|
Adipose Tissue, Brown | 1 | 2012 | 762 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5866 | 0.020 |
Why?
|
Young Adult | 2 | 2023 | 59191 | 0.020 |
Why?
|
Metformin | 1 | 2013 | 906 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10507 | 0.020 |
Why?
|
Fibronectins | 1 | 2009 | 723 | 0.020 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2009 | 1128 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 1998 | 7583 | 0.010 |
Why?
|
Causality | 1 | 2011 | 1241 | 0.010 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 1186 | 0.010 |
Why?
|
Medicaid | 1 | 2017 | 2814 | 0.010 |
Why?
|
Stroke Volume | 1 | 2018 | 5486 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2016 | 3310 | 0.010 |
Why?
|
Adiposity | 1 | 2014 | 1879 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16968 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2012 | 2382 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2018 | 3621 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3451 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2009 | 3088 | 0.010 |
Why?
|
Survival Analysis | 1 | 2015 | 10072 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2010 | 1882 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7373 | 0.010 |
Why?
|
RNA Interference | 1 | 2009 | 2829 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26183 | 0.010 |
Why?
|
Medicare | 1 | 2017 | 6774 | 0.010 |
Why?
|
Amitrole | 1 | 1998 | 8 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8209 | 0.010 |
Why?
|
Hydro-Lyases | 1 | 1998 | 94 | 0.010 |
Why?
|
Transcription Factor TFIID | 1 | 1998 | 150 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11069 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1998 | 813 | 0.010 |
Why?
|
Inflammation | 1 | 2017 | 10759 | 0.010 |
Why?
|
Genes, Fungal | 1 | 1998 | 439 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1998 | 1545 | 0.010 |
Why?
|
Histone Acetyltransferases | 1 | 1998 | 335 | 0.010 |
Why?
|
Gene Expression | 1 | 2009 | 7569 | 0.010 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 1998 | 493 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 1998 | 656 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9417 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1998 | 1490 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 30015 | 0.010 |
Why?
|
Cell Division | 1 | 1998 | 4457 | 0.010 |
Why?
|
Chronic Disease | 1 | 2005 | 9310 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1998 | 3730 | 0.010 |
Why?
|
Models, Genetic | 1 | 1998 | 3431 | 0.000 |
Why?
|
Protein Binding | 1 | 1998 | 9345 | 0.000 |
Why?
|